Trinds

company

About

Trinds is a new contract research organization

  • 11 - 50

Details

Last Funding Type
Series Unknown
Industries
Market Research
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS) is a specialized contract research organization (CRO).

They are a team of clinical trial specialists with focused expertise in neuromuscular and rare disease. They have 15+ years of experience in successful academic and pharma-sponsored clinical trials research and drug development programs. Their goals are centered around our clients and the patient community. Together their team has successfully set-up, run and completed key clinical trial programs. They provide four key areas of support to pharmaceutical, biotechnology industries, and academic investigators and clinical trial sites.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Trinds has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 19, 2016 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2016 Series Unknown 1 CureDuchenne Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Trinds is funded by 1 investors. CureDuchenne Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
CureDuchenne Ventures Yes Series Unknown